The FDA insisted on a combo trial. Why? Possibly b
Post# of 148246
(Total Views: 567)
Posted On: 07/18/2023 1:26:42 AM
The FDA insisted on a combo trial. Why? Possibly because Cytodyn could do a smaller phase 3 trial in combo therapy using the monotherapy data as support which would mean quicker approval. The FDA also wanted a combo trial so there was a backup drug because they didn't trust in the efficacy of leronlimab based on the results from maraviroc.
Maybe once the HIV trial data is published in a peer reviewed journal the FDA will get a clue.
Maybe once the HIV trial data is published in a peer reviewed journal the FDA will get a clue.
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼